Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul G Corn

Showing results (21-30 of 91) with videos related to

Pageof 10
Sort By:
JAMA Network Open|December 23, 2021
Association of Second-generation Antiandrogens With Depression Among Patients With Prostate CancerMalgorzata K Nowakowska, Xiudong Lei, Mackenzie R Wehner, et al.
Endocrine-Related Cancer|May 6, 2020
Fibroblast growth factors signaling in bone metastasisEstefania Labanca, Elba S Vazquez, Paul G Corn, et al.
International Journal of Radiation Oncology, Biology, Physics|April 2, 2013
Sunitinib plus androgen deprivation and radiation therapy for patients with localized high-risk prostate cancer: results from a multi-institutional phase 1 studyPaul G Corn, Danny Y Song, Elisabeth Heath, et al.
Carcinogenesis|January 23, 2003
Frequent hypermethylation of the 5' CpG island of the mitotic stress checkpoint gene Chfr in colorectal and non-small cell lung cancerPaul G Corn, Matthew K Summers, Franz Fogt, et al.
Cancer Biology & Therapy|November 20, 2008
Inhibition of Mxi1 suppresses HIF-2alpha-dependent renal cancer tumorigenesisChun Chui Tsao, Bin T Teh, Eric Jonasch, et al.
Cancer Biology & Therapy|December 2, 2005
Mxi1 is induced by hypoxia in a HIF-1-dependent manner and protects cells from c-Myc-induced apoptosisPaul G Corn, M Stacey Ricci, Kimberly A Scata, et al.
Genome Biology|July 8, 2020
Decoding the evolutionary response to prostate cancer therapy by plasma genome sequencingNaveen Ramesh, Emi Sei, Pei Ching Tsai, et al.
Clinical Genitourinary Cancer|December 4, 2014
Phase I trial of sunitinib and temsirolimus in metastatic renal cell carcinomaMatthew T Campbell, Randall E Millikan, Emre Altinmakas, et al.
BMC Cancer|September 8, 2016
The combination of serum insulin, osteopontin, and hepatocyte growth factor predicts time to castration-resistant progression in androgen dependent metastatic prostate cancer- an exploratory studyFarshid Dayyani, Amado J Zurita, Graciela M Nogueras-González, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2016
Paired High-Content Analysis of Prostate Cancer Cells in Bone Marrow and Blood Characterizes Increased Androgen Receptor Expression in Tumor Cell ClustersAnders Carlsson, Peter Kuhn, Madelyn S Luttgen, et al.
Pageof 10

Showing results (21-30 of 91) with videos related to

Sort By:
Pageof 10
JAMA Network Open|December 23, 2021
Association of Second-generation Antiandrogens With Depression Among Patients With Prostate CancerMalgorzata K Nowakowska, Xiudong Lei, Mackenzie R Wehner, et al.
Endocrine-Related Cancer|May 6, 2020
Fibroblast growth factors signaling in bone metastasisEstefania Labanca, Elba S Vazquez, Paul G Corn, et al.
International Journal of Radiation Oncology, Biology, Physics|April 2, 2013
Sunitinib plus androgen deprivation and radiation therapy for patients with localized high-risk prostate cancer: results from a multi-institutional phase 1 studyPaul G Corn, Danny Y Song, Elisabeth Heath, et al.
Carcinogenesis|January 23, 2003
Frequent hypermethylation of the 5' CpG island of the mitotic stress checkpoint gene Chfr in colorectal and non-small cell lung cancerPaul G Corn, Matthew K Summers, Franz Fogt, et al.
Cancer Biology & Therapy|November 20, 2008
Inhibition of Mxi1 suppresses HIF-2alpha-dependent renal cancer tumorigenesisChun Chui Tsao, Bin T Teh, Eric Jonasch, et al.
Cancer Biology & Therapy|December 2, 2005
Mxi1 is induced by hypoxia in a HIF-1-dependent manner and protects cells from c-Myc-induced apoptosisPaul G Corn, M Stacey Ricci, Kimberly A Scata, et al.
Genome Biology|July 8, 2020
Decoding the evolutionary response to prostate cancer therapy by plasma genome sequencingNaveen Ramesh, Emi Sei, Pei Ching Tsai, et al.
Clinical Genitourinary Cancer|December 4, 2014
Phase I trial of sunitinib and temsirolimus in metastatic renal cell carcinomaMatthew T Campbell, Randall E Millikan, Emre Altinmakas, et al.
BMC Cancer|September 8, 2016
The combination of serum insulin, osteopontin, and hepatocyte growth factor predicts time to castration-resistant progression in androgen dependent metastatic prostate cancer- an exploratory studyFarshid Dayyani, Amado J Zurita, Graciela M Nogueras-González, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2016
Paired High-Content Analysis of Prostate Cancer Cells in Bone Marrow and Blood Characterizes Increased Androgen Receptor Expression in Tumor Cell ClustersAnders Carlsson, Peter Kuhn, Madelyn S Luttgen, et al.
Pageof 10